BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30905357)

  • 1. Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget's Diseases.
    Zhang G; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Mai R
    J Invest Dermatol; 2019 Apr; 139(4):789-795. PubMed ID: 30905357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
    Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
    Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
    Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
    Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of mucin genes in mammary and extramammary Paget's disease.
    Kuan SF; Montag AG; Hart J; Krausz T; Recant W
    Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.
    Keatings L; Sinclair J; Wright C; Corbett IP; Watchorn C; Hennessy C; Angus B; Lennard T; Horne CH
    Histopathology; 1990 Sep; 17(3):243-7. PubMed ID: 2173676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression status of HER2 in mammary and extramammary Paget's disease].
    Meng H; Zheng XY; Zhang L; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's disease.
    Giger O; Caduff R; O'Meara A; Diener PA; Knuth A; Jäger D; Moch H; Varga Z
    Pathol Int; 2010 Nov; 60(11):726-34. PubMed ID: 20946522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases.
    Liu W; Iqbal J; Khoury T
    J Cutan Pathol; 2010 Nov; 37(11):1145-9. PubMed ID: 19719834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
    Liegl B; Horn LC; Moinfar F
    Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells.
    Lundquist K; Kohler S; Rouse RV
    Am J Surg Pathol; 1999 Feb; 23(2):212-9. PubMed ID: 9989849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced E-cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget's disease of the breast.
    Ellis PE; Cano SD; Fear M; Kelsell DP; Ghali L; Crow JC; Perrett CW; MacLean AB
    Mod Pathol; 2008 Oct; 21(10):1192-9. PubMed ID: 18469796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 oncogene amplification in extramammary Paget's disease.
    Tanskanen M; Jahkola T; Asko-Seljavaara S; Jalkanen J; Isola J
    Histopathology; 2003 Jun; 42(6):575-9. PubMed ID: 12786893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epidermal growth factor receptor 2 expression in extramammary Paget's disease and mammary Paget's disease.
    Jeong SH; Hyeong JH; Park EJ; Kim KJ; Kim KH
    Australas J Dermatol; 2022 Feb; 63(1):115-118. PubMed ID: 34964488
    [No Abstract]   [Full Text] [Related]  

  • 14. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma.
    Soini Y
    Hum Pathol; 2004 Dec; 35(12):1531-6. PubMed ID: 15619213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 molecular subtype is a dominant subtype of mammary Paget's cells. An immunohistochemical study.
    Sek P; Zawrocki A; Biernat W; Piekarski JH
    Histopathology; 2010 Oct; 57(4):564-71. PubMed ID: 20955381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease.
    Wolber RA; Dupuis BA; Wick MR
    Am J Clin Pathol; 1991 Aug; 96(2):243-7. PubMed ID: 1713741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbiased Detection of Driver Mutations in Extramammary Paget Disease.
    Ishida Y; Kakiuchi N; Yoshida K; Inoue Y; Irie H; Kataoka TR; Hirata M; Funakoshi T; Matsushita S; Hata H; Uchi H; Yamamoto Y; Fujisawa Y; Fujimura T; Saiki R; Takeuchi K; Shiraishi Y; Chiba K; Tanaka H; Otsuka A; Miyano S; Kabashima K; Ogawa S
    Clin Cancer Res; 2021 Mar; 27(6):1756-1765. PubMed ID: 33323405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics.
    Cho WC; Ding Q; Wang WL; Nagarajan P; Curry JL; Torres-Cabala CA; Ivan D; Albarracin CT; Sahin A; Prieto VG; Aung PP
    J Cutan Pathol; 2023 May; 50(5):434-440. PubMed ID: 36808637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genetic alterations in extramammary Paget disease using whole exome analysis.
    Kiniwa Y; Yasuda J; Saito S; Saito R; Motoike IN; Danjoh I; Kinoshita K; Fuse N; Yamamoto M; Okuyama R
    J Dermatol Sci; 2019 Apr; 94(1):229-235. PubMed ID: 31023612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers.
    Ramachandra S; Gillett CE; Millis RR
    Virchows Arch; 1996 Dec; 429(6):371-6. PubMed ID: 8982382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.